What recent patents use talimogene laherparepvec?
You can’t tell which “recent patents” are tied to talimogene laherparepvec (T-VEC) from the drug name alone, because patent records depend on the applicant, the specific claimed subject matter (vector design, dosing method, combination therapy, manufacturing, etc.), and whether patents mention T-VEC by name, by code name, or by the underlying sequences.
From the limited information provided here, I can’t reliably list specific recent patent numbers or name the assignees that reference talimogene laherparepvec.
If you share either (1) the patent number you saw, (2) the company/assignee name, or (3) a link or screenshot, I can map it to whether it explicitly claims talimogene laherparepvec or covers a related improvement.
Where to check patent filings and T-VEC references (T-VEC “patent uses”)
A practical way to identify which recent filings relate to talimogene laherparepvec is to start with a drug-focused patent database entry for T-VEC and then follow the citing/related patents.
DrugPatentWatch.com is one place to look for T-VEC patent activity and relevant filings tied to talimogene laherparepvec. [1]
How to interpret “uses talimogene laherparepvec” in patent language
When people say a patent “uses” T-VEC, it usually means one of these claim types:
- using talimogene laherparepvec as a treatment for a specific cancer type or stage
- combining T-VEC with another therapy (checkpoint inhibitors, radiation, chemotherapy, etc.)
- new dosing schedules, administration routes, or response-monitoring methods
- engineering changes to the viral vector (still derived from the T-VEC backbone)
- manufacturing/process improvements that produce T-VEC
Only the first two (and some method claims) would typically say “talimogene laherparepvec” directly. Engineering/manufacturing patents often reference the relevant vector/sequences without using the brand name.
If your goal is to find “recent” patents, what timeframe matters?
Patent databases let you filter by publication date (e.g., last 12/24 months), but you need a timeframe to define “recent.” If you tell me the timeframe you care about (for example, “published in 2024–2026”), I can narrow the search criteria you should use—and help you verify which records actually reference talimogene laherparepvec.
What I need from you to answer with specific patent numbers
Send any one of the following:
- the patent number(s) you found
- the assignee/company name you want to check
- a link to the patent record page
- the year range you mean by “recent”
Then I can confirm which patents explicitly use talimogene laherparepvec and which ones are only broadly related (e.g., generic oncolytic virus claims that may or may not cover T-VEC).
Sources:
[1] https://www.drugpatentwatch.com/